399441 生物医药
已收盘 05-15 15:00:00
资讯
新帖
简况
优宁维：公司主要面向高等院校、科研院所、医院和生物医药企业等科研端
证券之星 · 05-15 11:33
优宁维：公司主要面向高等院校、科研院所、医院和生物医药企业等科研端
九源基因(02566)更名为“杭州九源基因生物医药股份有限公司”
智通财经 · 05-11
九源基因(02566)更名为“杭州九源基因生物医药股份有限公司”
港股部分生物医药股走强！银诺医药-B涨超42%，三叶草生物-B涨超11%
老虎资讯综合 · 05-11
港股部分生物医药股走强！银诺医药-B涨超42%，三叶草生物-B涨超11%
港股生物医药板块多数走低
第一财经 · 05-11
港股生物医药板块多数走低
中国银行在沪宣布：1万亿元助力生物医药产业发展
上观新闻 · 05-07
中国银行在沪宣布：1万亿元助力生物医药产业发展
第七届上海创新创业青年50人论坛即将举行，项目路演聚焦人工智能、生物医药等五大赛道
蓝鲸财经 · 05-06
第七届上海创新创业青年50人论坛即将举行，项目路演聚焦人工智能、生物医药等五大赛道
港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心
智通财经 · 05-05
港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心
4月23日甘李药业跌9.44%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 04-23
4月23日甘李药业跌9.44%，招商国证生物医药指数(LOF)C基金重仓该股
两部门：重点推动生物医药研发外包等标准化建设
金吾财讯 · 04-23
两部门：重点推动生物医药研发外包等标准化建设
招商基金侯昊旗下招商国证生物医药一季报最新持仓，重仓药明康德
证券之星 · 04-22
招商基金侯昊旗下招商国证生物医药一季报最新持仓，重仓药明康德
A股134家生物医药公司已披露年报 去年研发投入合计超604亿元
证券日报 · 04-15
A股134家生物医药公司已披露年报 去年研发投入合计超604亿元
四川：“十五五”期间打造一流生物医药创新服务体系 大力发展医药健康产业
金吾财讯 · 04-13
四川：“十五五”期间打造一流生物医药创新服务体系 大力发展医药健康产业
派格生物医药-B(02565)：中国证监会就本公司H股全流通申请发出备案通知书
智通财经 · 04-09
派格生物医药-B(02565)：中国证监会就本公司H股全流通申请发出备案通知书
鹭燕医药：公司未参与厦门生物医药产业链创新基金
证券之星 · 04-09
鹭燕医药：公司未参与厦门生物医药产业链创新基金
国信证券：全球生物医药投融资复苏 助推CXO行业需求向好
智通财经 · 04-08
国信证券：全球生物医药投融资复苏 助推CXO行业需求向好
全球生物医药巨头阿斯利康落子广州；深圳即将启用广东首个机器人停车场丨大湾区财经早参
每日经济新闻 · 04-08
全球生物医药巨头阿斯利康落子广州；深圳即将启用广东首个机器人停车场丨大湾区财经早参
安徽省药监局：化妆品监督抽检发现多批次不合格，涉大展生物医药
蓝鲸财经 · 04-07
安徽省药监局：化妆品监督抽检发现多批次不合格，涉大展生物医药
山西证券：生物医药定位国家支柱产业 创新药持续进入爆发期
智通财经 · 04-03
山西证券：生物医药定位国家支柱产业 创新药持续进入爆发期
派格生物医药-B(02565):CR059相关研究摘要获美国糖尿病协会2026年科学年会接收并入选最新突破性摘要
智通财经 · 04-02
派格生物医药-B(02565):CR059相关研究摘要获美国糖尿病协会2026年科学年会接收并入选最新突破性摘要
派格生物医药-B(02565)：郭恩廷获委任为联席公司秘书、授权代表及法律程序代理人
智通财经 · 04-01
派格生物医药-B(02565)：郭恩廷获委任为联席公司秘书、授权代表及法律程序代理人
暂无数据
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":2056.49,"timestamp":1778828601000,"preClose":2079.21,"halted":0,"volume":496520439,"delay":0,"changeRate":-0.0109,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-22.72,"latestTime":"05-15 15:00:00","open":2081.93,"high":2101.34,"low":2046.78,"amount":17053000000,"amplitude":0.0262,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":2079.21,"symbolType":"index","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441/tweets","defaultTab":"tweets","newsList":[{"id":"2635277918","title":"优宁维：公司主要面向高等院校、科研院所、医院和生物医药企业等科研端","url":"https://stock-news.laohu8.com/highlight/detail?id=2635277918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635277918?lang=zh_cn&edition=full","pubTime":"2026-05-15 11:33","pubTimestamp":1778816000,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维(301166)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问：冷总，公司在防病毒领域有没有设计相关产品？优宁维回复：投资者您好，公司主要面向高等院校、科研院所、医院和生物医药企业等科研端，提供生命科学试剂、设备、耗材、综合技术服务等产品和服务，产品覆盖基因、蛋白、细胞、组织及动物等不同水平的研究对象，助力生命科学的发展和创新。谢谢以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500018570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250","399441","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634829282","title":"九源基因(02566)更名为“杭州九源基因生物医药股份有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2634829282","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634829282?lang=zh_cn&edition=full","pubTime":"2026-05-11 21:19","pubTimestamp":1778505581,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因 发布公告，公司已于2025年4月17日取得香港公司注册处处长签发的注册非香港公司变更名称注册证明书，确认根据公司条例第16部在香港注册的公司英文名称已由“Hangzhou Jiuyuan Gene Engineering Co., Ltd.”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.”，而中文名称已由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”。更改公司名称后，公司的股份代号、中文股票简称及英文股票简称保持不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4581","02566","161726","399441","BK4588","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188980056","title":"港股部分生物医药股走强！银诺医药-B涨超42%，三叶草生物-B涨超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188980056","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188980056?lang=zh_cn&edition=full","pubTime":"2026-05-11 13:25","pubTimestamp":1778477154,"startTime":"0","endTime":"0","summary":"5月11日，港股部分生物医药股走强，$银诺医药-B(02591)$涨超42%，$三叶草生物-B(02197)$涨超11%，$君实生物(01877)$涨超8%，$来凯医药-B(02105)$涨超7%，$荃信生物-B(02509)$涨近5%，$药明巨诺-B(02126)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"68e9cc22a457e84dfc55ae6520639fb8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","02591","161726","BK1161","399441","02197","BK4585","VXUS","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634473684","title":"港股生物医药板块多数走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2634473684","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634473684?lang=zh_cn&edition=full","pubTime":"2026-05-11 09:58","pubTimestamp":1778464732,"startTime":"0","endTime":"0","summary":"港股生物医药板块多数走低","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113732760661.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113732760661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VXUS","XBI","BK4588","BK4581","BK4585","399441","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633140242","title":"中国银行在沪宣布：1万亿元助力生物医药产业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2633140242","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633140242?lang=zh_cn&edition=full","pubTime":"2026-05-07 21:00","pubTimestamp":1778158846,"startTime":"0","endTime":"0","summary":"生物医药产业迎来一场及时雨。5月7日，中国银行在上海发布《支持生物医药全链条创新发展行动方案》，将在“十五五”期间，为生物医药全产业链提供不少于1万亿元综合金融支持，以金融活水助力这一新兴产业迈向新高度。中国银行在上海发布《支持生物医药全链条创新发展行动方案》根据方案，中国银行将聚焦长三角、京津冀、大湾区、成渝等核心集聚区，助力构建政策引导、科技推动、金融赋能的产业生态体系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605073730398873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU2097828557.USD","BK0183","LU1497733631.SGD","BK0012","LU1497734951.SGD","LU1515016050.SGD","BK1560","LU0348805143.USD","399441","LU1634259557.SGD","LU2097828631.EUR","161726","LU0588546209.SGD","LU0072462343.USD","LU1048588211.SGD","LU1051768304.USD","LU2097828805.USD","LU1282651048.USD","BK4588","03988","LU1224444064.USD","LU2097828714.EUR","BK4581","XBI","BK1231","LU1051769294.HKD","LU1522347837.USD","LU0651947912.USD","LU1497733557.USD","03143","LU2097828474.EUR","IE00BWDBJ730.SGD","LU0293314216.USD","LU0651946864.USD","HK0000286598.CNH","SG9999006597.SGD","BK0278","SG9999001093.SGD","BK0028","IE00B19Z5X02.USD","LU0307460666.USD","LU1282651121.HKD","BK0015","LU1634259391.SGD","BK0188","601988","IE00BQJZWZ67.USD","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633181277","title":"第七届上海创新创业青年50人论坛即将举行，项目路演聚焦人工智能、生物医药等五大赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2633181277","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633181277?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:46","pubTimestamp":1778064383,"startTime":"0","endTime":"0","summary":"图片来源：视觉中国蓝鲸新闻5月6日讯记者获悉，第七届上海创新创业青年50人论坛将于2026年5月10日在上海中心举行，以“青年与城市共成长”为主题，包含主论坛与青年科创嘉年华两大活动板块。上海高校创新创业共同体作为本届论坛重磅发布的长效机制平台，将在青年科创嘉年华上海交通大学分会场正式启动。同时，论坛将推出2026上海青年创新创业研修营，并发布上海青年创新创业政策服务包。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1778064184167321209","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["399441","161726","XBI","BK4585","CHAT","BK4588","161631","BK4581","161022","ARTY","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633990288","title":"港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2633990288","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633990288?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:03","pubTimestamp":1777968239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，派格生物医药-B今日走势强劲，盘中最高涨18.91%，报29.3港元，成交额达5965.98万港元。消息面上，派格生物医药近期公布，基石投资者同意自愿禁售期届满日起至5月20日不会以任何方式减持任何持股。公司认为，禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438070.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","BK1161","BK4581","XBI","399441","BK4588","02565","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629886570","title":"4月23日甘李药业跌9.44%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629886570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629886570?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:24","pubTimestamp":1776932643,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日甘李药业跌9.44%，收盘报59.48元，换手率3.86%，成交量21.51万手，成交额13.09亿元。重仓甘李药业的前十大公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共42家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.1亿元，最新净值0.398，较上一交易日上涨0.45%，近一年上涨13.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300044541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399441","603087","BK0239","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629064450","title":"两部门：重点推动生物医药研发外包等标准化建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2629064450","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629064450?lang=zh_cn&edition=full","pubTime":"2026-04-23 12:26","pubTimestamp":1776918412,"startTime":"0","endTime":"0","summary":"金吾财讯 | 商务部、市场监管总局印发《服务贸易标准化工作行动计划（2026—2030年）》。其中提到，加大知识产权、科技服务、地理信息、人力资源、语言、咨询、检验检测、创意设计服务等领域的标准研制力度，推动相关标准覆盖行业境内外服务提供的全链条，提升专业服务机构的国际化服务能力。提升服务外包标准化水平，重点推动生物医药研发外包、与制造业融合发展信息技术外包、服务外包企业知识产权保护等方面的标准化建设。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/YWM4OGFlZWVjMzgwOWEyMjFjMjcxMjc0NzUxMTA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/YWM4OGFlZWVjMzgwOWEyMjFjMjcxMjc0NzUxMTA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979745","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","399441","BK4588","BK4581","XBI","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629069196","title":"招商基金侯昊旗下招商国证生物医药一季报最新持仓，重仓药明康德","url":"https://stock-news.laohu8.com/highlight/detail?id=2629069196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629069196?lang=zh_cn&edition=full","pubTime":"2026-04-22 07:12","pubTimestamp":1776813167,"startTime":"0","endTime":"0","summary":"证券之星消息，4月22日招商基金旗下侯昊 许荣漫管理的招商国证生物医药指数基金(LOF)公布一季报，近1年净值增长率12.57%。与上一季度相比，该基金前十大重仓股新增凯莱英，荣昌生物；其中药明康德持仓占比10.57%，为该基金第一大重仓股；智飞生物，爱美客等退出前十大重仓股；详细数据如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200013447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997245094.SGD","LU1979443071.USD","399441","LU0348767384.USD","LU0456842615.SGD","603259","02359","BK1576","BK0216","LU0348766576.USD","LU1997244956.HKD","LU2242644610.SGD","BK1583","161726","BK1141","LU0052750758.USD","LU1934453819.USD","LU1969619763.USD","LU1808992512.USD","LU2045819591.USD","LU2328871848.SGD","LU2488822045.USD","LU1046422090.SGD","LU2125910500.SGD","LU2495084118.USD","LU1997245177.USD","LU0708995583.HKD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627425790","title":"A股134家生物医药公司已披露年报 去年研发投入合计超604亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627425790","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627425790?lang=zh_cn&edition=full","pubTime":"2026-04-15 00:43","pubTimestamp":1776184980,"startTime":"0","endTime":"0","summary":"东方财富Choice数据显示，截至4月14日《证券日报》记者发稿，已有134家A股生物医药上市公司披露2025年年报。整体来看，行业去年营收、净利润稳步增长，研发投入持续加大，超三成企业实现营收与净利润双增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153704919257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","399441","XBI","161726","BK4588","159982","399300","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627483650","title":"四川：“十五五”期间打造一流生物医药创新服务体系 大力发展医药健康产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2627483650","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627483650?lang=zh_cn&edition=full","pubTime":"2026-04-13 10:36","pubTimestamp":1776047784,"startTime":"0","endTime":"0","summary":"其中提出，深入实施六大优势产业提质倍增行动，分业施策推动重点产业领域优化结构、提质升级。引导食品饮料、轻工纺织等行业以品种、质量、效率、绿色、安全为发展重点，扩大适应需求的新型消费供给。加快医学、医疗、医药融合发展，打造一流生物医药创新服务体系，大力发展医药健康产业。推动建筑业高质量发展。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/ZDMzODA5NjAwODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDMzODA5NjAwODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1978729","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","161726","399441","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626821185","title":"派格生物医药-B(02565)：中国证监会就本公司H股全流通申请发出备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2626821185","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626821185?lang=zh_cn&edition=full","pubTime":"2026-04-09 18:27","pubTimestamp":1775730460,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，本公司已收到中国证监会就实施H股全流通而发出日期为2026年3月26日的备案通知书。根据备案通知书，本公司就合计1.02亿股未上市股份实施H股全流通向中国证监会作出的备案已经完成。倘自备案通知书日期起计12个月内未完成股份转换，且本公司仍有意进行该转换，则本公司应当向中国证监会更新备案材料。本公司将向联交所申请批准该等H股于联交所主板上市及买卖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","XBI","161726","399441","BK1161","02565","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626643907","title":"鹭燕医药：公司未参与厦门生物医药产业链创新基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2626643907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626643907?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:39","pubTimestamp":1775723949,"startTime":"0","endTime":"0","summary":"证券之星消息，鹭燕医药(002788)04月09日在投资者关系平台上答复投资者关心的问题。投资者提问：您好尊敬的董秘：鹭燕医药是否有参与厦门生物医药产业链创新基金？参与资金是多少？鹭燕医药回复：公司未参与厦门生物医药产业链创新基金。公司严格履行信息披露义务，公司的重大信息请以公司公告为准，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900026151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","399441","161726","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625788996","title":"国信证券：全球生物医药投融资复苏 助推CXO行业需求向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2625788996","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625788996?lang=zh_cn&edition=full","pubTime":"2026-04-08 10:19","pubTimestamp":1775614767,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国信证券发布研报称，全球生物医药投融资明确复苏，2025年融资额同比增长4%，为CXO行业注入增长动力。CDMO方面，全球药品市场的平稳增长为CDMO行业筑牢需求根基，新分子疗法的爆发式增长更开辟了核心增量空间；CRO方面，作为研发链条的核心环节，其受投融资复苏的驱动更为直接，业绩兑现的确定性与增长弹性显著增强，行业景气度持续上行。临床前CRO领域，实验动物相关订单已率先触底反弹，后续增长确定性增强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK0183","BK0028","161726","399441","BK4585","BK0188","BK0276","CXO","BK4581","002736","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625027964","title":"全球生物医药巨头阿斯利康落子广州；深圳即将启用广东首个机器人停车场丨大湾区财经早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2625027964","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625027964?lang=zh_cn&edition=full","pubTime":"2026-04-08 07:05","pubTimestamp":1775603119,"startTime":"0","endTime":"0","summary":"｜2026年4月8日星期三｜NO.1清明假期广东旅游收入超百亿元“广东发布”微信公众号4月7日消息，据初步测算，2026年清明假期三天（4月4日至6日），广东接待游客1985.1万人次，实现旅游收入104.3亿元。点评：百亿文旅收入印证广东内需韧性、消费活力、湾区磁吸效应，为一季度经济收官、二季度内需扩容打下坚实基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604083696940526.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604083696940526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0320765992.SGD","LU2237443895.HKD","BK4568","LU2237443549.SGD","LU2237443978.SGD","IE00B3T34201.USD","LU0289739699.SGD","BK4581","LU2462157665.USD","LU2417539215.USD","BK4585","LU0058720904.USD","LU2237443622.USD","AZN","BK4007","159983","LU2237443465.HKD","LU1829250122.USD","161726","399441","XBI","LU0109394709.USD","LU2456880835.USD","LU2237443382.USD","BK4588","LU2236285917.USD","LU0889565916.HKD","ROBO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625468984","title":"安徽省药监局：化妆品监督抽检发现多批次不合格，涉大展生物医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2625468984","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625468984?lang=zh_cn&edition=full","pubTime":"2026-04-07 13:22","pubTimestamp":1775539320,"startTime":"0","endTime":"0","summary":"蓝鲸新闻4月7日讯，安徽省药品监督管理局于2026年3月25日发布《2026年第1期化妆品监督抽检质量通告》，通报全省化妆品监督抽检中发现的不符合规定产品。抽检问题主要集中在微生物超标、标签标识不规范、检出禁用原料及实际成分与备案配方不符等方面。针对不合格批次，属地市场监管部门已责令相关企业立即停止销售、下架召回，并开展原因排查与整改；省药监局同步要求依法查处并公开处理结果。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775539077210443845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4588","BK4585","XBI","399441","161726","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624631507","title":"山西证券：生物医药定位国家支柱产业 创新药持续进入爆发期","url":"https://stock-news.laohu8.com/highlight/detail?id=2624631507","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624631507?lang=zh_cn&edition=full","pubTime":"2026-04-03 10:07","pubTimestamp":1775182063,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，山西证券发布研报称，2026年全国两会期间，生物医药产业成为国家政策重点支持产业。国家已将生物医药上升为新兴支柱产业，国产创新药也迎来持续的爆发阶段。国产创新药已成为生物医药产业核心发展方向，已进入持续爆发期2025年是中国创新药出海爆发式增长的一年，各项数据均创下历史新高。2026开年，中国创新药BD出海已展现出延续2025年的势头。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK0028","BK4581","159992","002500","BK0183","161726","06978","BK1574","BK4585","XBI","BK0188","BK0276","399441","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624503214","title":"派格生物医药-B(02565):CR059相关研究摘要获美国糖尿病协会2026年科学年会接收并入选最新突破性摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2624503214","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624503214?lang=zh_cn&edition=full","pubTime":"2026-04-02 19:15","pubTimestamp":1775128554,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B 发布公告，集团自主研发的创新候选产品CR059 相关研究摘要已获美国糖尿病协会2026年科学年会接收，并入选Late Breaking Abstract，将以海报形式展示。根据相关研究结果，CR059展现出显著减重效果、突出的降糖表现及长期表达特征，并显示出作为长效代谢疾病治疗方案的开发潜力。美国糖尿病协会科学年会是糖尿病及代谢疾病领域具有国际影响力的学术会议之一。根据会议安排，上述研究摘要将于ADA 2026年科学年会期间以海报形式展示。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","BK4581","BK4585","399441","BK4588","BK1161","XBI","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624047597","title":"派格生物医药-B(02565)：郭恩廷获委任为联席公司秘书、授权代表及法律程序代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2624047597","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624047597?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:01","pubTimestamp":1775041287,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，邹醒龙先生(邹先生)已辞任本公司联席公司秘书(联席公司秘书); 香港联合交易所有限公司证券上市规则第 3.05条项下的本公司授权代表(授权代表); 及根据香港法例第622章公司条例第16部代表本公司于香港接收法律程序文件及通知的代表(法律程序代理人)， 自 2026年4月1日起生效。自邹先生辞任联席公司秘书、授权代表及法律程序代理人后，郭恩廷女士(郭女士)已获委任为联席公司秘书、授权代表及法律程序代理人，自2026年4月1日起生效。黄一峰先生(黄先生)将继续担任另一名联席公司秘书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","BK4588","02565","BK4585","161726","BK4581","XBI","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778942142326,"stockEarnings":[{"period":"1week","weight":-0.0324},{"period":"1month","weight":-0.083},{"period":"3month","weight":-0.054},{"period":"6month","weight":-0.1255},{"period":"1year","weight":0.0519},{"period":"ytd","weight":-0.0417}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}